Blog
RSS FeedPosted by Michael Wonder on 12 Aug 2019
Cystic fibrosis drugs rejected for use by NHS in Scotland
12 August 2019 - Two "life-changing" cystic fibrosis drugs have been rejected for routine use by the NHS in Scotland. ...
Posted by Michael Wonder on 12 Aug 2019
SMC - August 2019 decisions
12 August 2019 - The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has today ...
Posted by Michael Wonder on 08 Jul 2019
New treatment approved for patients with breast cancer in Scotland
8 July 2019 - A new drug for patients with advanced breast cancer has been approved for use by the ...
Posted by Michael Wonder on 08 Jul 2019
SMC - July 2019 decisions
8 July 2019 - A medicine used to treat advanced breast cancer has today been accepted by the Scottish Medicines ...
Posted by Michael Wonder on 10 Jun 2019
SMC - June 2019 decisions
10 June 2019 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...
Posted by Michael Wonder on 13 May 2019
New cancer drugs approved for NHS use in Scotland
13 May 2019 - The Scottish Medicines Consortium accepted the use of new medicines to treat patients with breast and skin ...
Posted by Michael Wonder on 13 May 2019
SMC - May 2019 decisions
13 May 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...
Posted by Michael Wonder on 12 Mar 2019
SMC says ‘no’ to Novartis’ Kymriah for adults with lymphoma
11 March 2019 - Adults with lymphoma will not be able to access Novartis’ CAR-T therapy Kymriah on the NHS ...
Posted by Michael Wonder on 11 Mar 2019
SMC - March 2019 decisions
11 March 2019 - The Scottish Medicines Consortium has today published advice accepting two new medicines. ...
Posted by Michael Wonder on 12 Feb 2019
Yescarta rejected among other SMC decisions
12 February 2019 - Gilead's CAR-T therapy Yescarta (axicabtagene ciloleucel) has been rejected by the Scottish Medicines Consortium (SMC) for ...
Posted by Michael Wonder on 11 Feb 2019
SMC - February 2019 decisions
11 February 2019 - A medicine used to treat a rare blood cancer in children and young adults has today ...
Posted by Michael Wonder on 14 Jan 2019
Life-extending drug Perjeta approved for secondary breast cancer
14 January 2019 - A drug used to treat advanced breast cancer has been approved for use on the NHS ...
Posted by Michael Wonder on 14 Jan 2019
SMC - January 2019 decisions
14 January 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...
Posted by Michael Wonder on 10 Dec 2018
Perjeta given green light in Scotland as early stage breast cancer treatment
10 December 2018 - Hundreds of breast cancer patients are expected to benefit after a sought-after drug was approved for ...
Posted by Michael Wonder on 10 Dec 2018
SMC - December 2018 decisions
10 December 2018 - A medicine used to treat early stage breast cancer has been accepted by the SMC for ...